Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.42 USD | -2.43% | -0.30% | -0.30% |
May. 14 | Wedbush Adjusts Voyager Therapeutics' PT to $8 From $10, Keeps Neutral Rating | MT |
May. 13 | Transcript : Voyager Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Official Publications
No official publication found
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Official Publications